266 related articles for article (PubMed ID: 12668523)
1. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.
Gerber IL; Stewart RA; Legget ME; West TM; French RL; Sutton TM; Yandle TG; French JK; Richards AM; White HD
Circulation; 2003 Apr; 107(14):1884-90. PubMed ID: 12668523
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.
Bergler-Klein J; Klaar U; Heger M; Rosenhek R; Mundigler G; Gabriel H; Binder T; Pacher R; Maurer G; Baumgartner H
Circulation; 2004 May; 109(19):2302-8. PubMed ID: 15117847
[TBL] [Abstract][Full Text] [Related]
3. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation.
Sutton TM; Stewart RA; Gerber IL; West TM; Richards AM; Yandle TG; Kerr AJ
J Am Coll Cardiol; 2003 Jun; 41(12):2280-7. PubMed ID: 12821260
[TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
[TBL] [Abstract][Full Text] [Related]
5. [Role of natriuretic peptides in the assessment of aortic stenosis severity].
Davicević Z; Tavciovski D; Matunović R; Vukotić S; Mijailović Z
Vojnosanit Pregl; 2010 Aug; 67(8):622-6. PubMed ID: 20845663
[TBL] [Abstract][Full Text] [Related]
6. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
8. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration.
Gerber IL; Legget ME; West TM; Richards AM; Stewart RA
Am J Cardiol; 2005 Apr; 95(7):898-901. PubMed ID: 15781029
[TBL] [Abstract][Full Text] [Related]
10. Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asymptomatic Patients With Aortic Stenosis.
Henri C; Dulgheru R; Magne J; Caballero L; Laaraibi S; Davin L; Kou S; Voilliot D; Nchimi A; Oury C; Pierard LA; Lancellotti P
Can J Cardiol; 2016 Feb; 32(2):183-9. PubMed ID: 26371385
[TBL] [Abstract][Full Text] [Related]
11. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
12. Clinical and echocardiographic correlates of plasma B-type natriuretic peptide levels in patients with aortic valve stenosis and normal left ventricular ejection fraction.
Maréchaux S; Hattabi M; Juthier F; Neicu DV; Richardson M; Carpentier E; Bouabdallaoui N; Delelis F; Banfi C; Breyne J; Jude B; Asseman P; Vincentelli A; Le Tourneau T; Graux P; Pibarot P; Ennezat PV
Echocardiography; 2011 Aug; 28(7):695-702. PubMed ID: 21564276
[TBL] [Abstract][Full Text] [Related]
13. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
14. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.
Antonini-Canterin F; Popescu BA; Popescu AC; Beladan CC; Korcova R; Piazza R; Cappelletti P; Rubin D; Cassin M; Faggiano P; Nicolosi GL
Int J Cardiol; 2008 Aug; 128(3):406-12. PubMed ID: 17662495
[TBL] [Abstract][Full Text] [Related]
15. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.
Weber M; Arnold R; Rau M; Brandt R; Berkovitsch A; Mitrovic V; Hamm C
Am J Cardiol; 2004 Sep; 94(6):740-5. PubMed ID: 15374777
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.
Farré N; Gómez M; Molina L; Cladellas M; Blé M; Roqueta C; Ascoeta MS; Comin-Colet J; Vila J; Bruguera J
Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):52-7. PubMed ID: 24774264
[TBL] [Abstract][Full Text] [Related]
17. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis.
Pedrazzini GB; Masson S; Latini R; Klersy C; Rossi MG; Pasotti E; Faletra FF; Siclari F; Minervini F; Moccetti T; Auricchio A
Am J Cardiol; 2008 Sep; 102(6):749-54. PubMed ID: 18774001
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival.
Clavel MA; Malouf J; Michelena HI; Suri RM; Jaffe AS; Mahoney DW; Enriquez-Sarano M
J Am Coll Cardiol; 2014 May; 63(19):2016-25. PubMed ID: 24657652
[TBL] [Abstract][Full Text] [Related]
19. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide.
Lim P; Monin JL; Monchi M; Garot J; Pasquet A; Hittinger L; Vanoverschelde JL; Carayon A; Gueret P
Eur Heart J; 2004 Nov; 25(22):2048-53. PubMed ID: 15541842
[TBL] [Abstract][Full Text] [Related]
20. Transcardiac gradients of N-terminal B-type natriuretic peptide in aortic valve stenosis.
Kupari M; Turto H; Lommi J; Mäkijärvi M; Parikka H
Eur J Heart Fail; 2005 Aug; 7(5):809-14. PubMed ID: 16087135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
